nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2026-30-1-56-59COOGZKnefr-2522Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSОтдаленные последствия COVID-19 для почек: управляемое осложнение или бомба замедленного действия?Long-term consequences of COVID-19 for kidneys: a manageable complication or a time bomb?https://orcid.org/0000-0003-1773-9971ФедулкинаВ. А.FedulkinaV. A.

Старший научный сотрудник Федулкина Вероника Андреевна, канд. мед. наук, хирургическое отделение трансплантации почки

129110, Москва, ул. Щепкина, д. 61/2

Тел.: 8(495)684-57-91

Senior researcher Fedulkina Veronika Andreevna, MD, PhD, surgical department of kidney transplantation 

129110, Moscow, st. Shchepkina, 61/2

Tel.: 8(495)684-57-91

v.fedulkina@mail.ruhttps://orcid.org/0000-0002-6010-8975АртамоноваА. А.ArtamonovaA. A.

Старший научный сотрудник Артамонова Александра Анатольевна, канд. мед. наук, хирургическое отделение трансплантации почки

129110, Москва, ул. Щепкина, д. 61/2

Тел.: 8(495)684-57-91

Senior researcher Artamonova Alexandra Anatolyevna, MD, PhD, surgical department of kidney transplantation

129110, Moscow, st. Shchepkina, 61/2

Tel.: 8(495)684-57-91

aartamonova@yandex.ruhttps://orcid.org/0000-0001-5405-7887ЗулькарнаевА. Б.ZulkarnaevA. B.

Главный научный сотрудник Зулькарнаев Алексей Батыргараевич, д-р мед. наук, хирургическое отделение трансплантации почки

129110, Москва, ул. Щепкина, д. 61/2

Тел.: 8(495)684-57-91

Major researcher. Zulkarnaev Alexey Batirgaraevich, MD, DMedSci, surgical department of kidney transplantation

129110, Moscow, st. Shchepkina, 61/2

Tel.: 8(495)684-57-91

7059899@gmail.comМосковский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоРоссияMoscow Regional Research Clinical Institute named after. M.F. VladimirskyRussian Federation2026090320263015659Copyright © Федулкина В.А., Артамонова А.А., Зулькарнаев А.Б., 20262026Федулкина В.А., Артамонова А.А., Зулькарнаев А.Б.Fedulkina V.A., Artamonova A.A., Zulkarnaev A.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/2522

Влияние COVID-19 на хроническую болезнь почек (ХБП) уже подтверждено исследователями по всему миру. Однако до сих пор в литературе недостаточно данных о том, как новая коронавирусная инфекция может влиять на функцию почек без признаков ХБП до этого. Целью данного исследования являлось определить относительный риск развития 4–5 стадий ХБП у пациентов, перенесших COVID-19 и не имевших признаков поражения почек до этого, в зависимости от тяжести течения коронавирусной инфекции, факта госпитализации и осложнения в виде острого повреждения почек. Результаты работы демонстрируют, что развитие поздних (4–5) стадий ХБП может быть напрямую связано с перенесенным COVID-19, особенно у пациентов с тяжелой формой COVID-19, госпитализацией или острым повреждением почек, что согласуется со многими исследованиями в этой области, в частности у пациентов без признаков ХБП до этого.

The impact of COVID-19 on chronic kidney disease (CKD) has already been confirmed by researchers around the world. However, there is still insufficient data in the literature how the new coronavirus infection can affect kidney function without signs of CKD before. The aim of this study was to determine the relative risk of developing stages 4-5 CKD in patients who had COVID-19 and did not have signs of kidney damage before, depending on the severity of the coronavirus infection, the fact of hospitalization and the complication of acute kidney injury. The results of the study demonstrate that the development of late (4-5) stages of CKD can be directly associated with COVID-19, especially in patients with severe COVID-19, hospitalization or acute kidney injury, which is consistent with many studies in this area, in particular in patients without signs of CKD before.

COVID-19SARS-CoV-2коронавирусострое повреждение почекхроническая болезнь почекотдаленные последствияCOVID-19SARS-CoV-2coronavirusacute kidney injurychronic kidney diseaselong-term consequencesReferencesCDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States. February 12 – March 28. Weekly 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States. February 12 – March 28. Weekly 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032COVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020 [Internet]. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdfCOVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020 [Internet]. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdfКравченко АЯ, Концевая АВ, Будневский АВ, Черник ТА. Новая коронавирусная инфекция (COVID-19) и патология почек. Профилактическая медицина 2022;25(3):92–97Kravchenko AYa, Kontsevaya AV, Budnevsky AV, Chernik TA. Novel coronavirus infection (COVID-19) and kidney disease. Profilakticheskaya Meditsina 2022;25(3):92–97. (In Russ.) doi: 10.17116/profmed20222503192Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9/Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9/Suleyman G, Fadel RA, Malette KM et al. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open 2020;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270Suleyman G, Fadel RA, Malette KM et al. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open 2020;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270Томилина НА, Фролова НФ, Артюхина ЛЮ и др. COVID-19: связь с патологией почек. Обзор литературы. Нефрология и диализ 2021;23(2):147–159. doi: 10.28996/2618-9801-2021-2-147-159Tomilina NA, Frolova NF, Artyuhina LYU et al. COVID-19: relationship with kidney diseases. Literature review. Nephrology and dialysis 2021; 23(2):147–159. (In Russ.) doi: 10.28996/2618-9801-2021-2-147-159Duarsa GWK, Sugianto R, Yusari IGAAA et al. Method for determining predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019 in a systematic review and meta-analysis research. MethodsX 2023;11:102250. doi: 10.1016/j.mex.2023.102250Duarsa GWK, Sugianto R, Yusari IGAAA et al. Method for determining predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019 in a systematic review and meta-analysis research. MethodsX 2023;11:102250. doi: 10.1016/j.mex.2023.102250Ghaffari Rahbar M, Nafar M, Khoshdel A et al. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22(5):e13406. doi: 10.1111/tid.13406Ghaffari Rahbar M, Nafar M, Khoshdel A et al. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22(5):e13406. doi: 10.1111/tid.13406Caillard S, Anglicheau D, Matignon M et al. French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98(6):1549–1558. doi: 10.1016/j.kint.2020.08.005Caillard S, Anglicheau D, Matignon M et al. French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98(6):1549–1558. doi: 10.1016/j.kint.2020.08.005Santeusanio AD, Menon MC, Liu C et al. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19). Clin Transplant 2021;35(4):e14221. doi: 10.1111/ctr.14221Santeusanio AD, Menon MC, Liu C et al. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19). Clin Transplant 2021;35(4):e14221. doi: 10.1111/ctr.14221Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Hirsch JS, Ng JH, Ross DW et al. Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209–218. doi: 10.1016/j.kint.2020.05.006Hirsch JS, Ng JH, Ross DW et al. Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209–218. doi: 10.1016/j.kint.2020.05.006Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775Temiz MZ, Hacibey I, Yazar RO et al. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022;44(1):233–240. doi: 10.1080/0886022X.2022.2032743Temiz MZ, Hacibey I, Yazar RO et al. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022;44(1):233–240. doi: 10.1080/0886022X.2022.2032743Filev R, Rostaing L, Lyubomirova M et al. COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury. J Pers Med 2022;12(10):1676. doi: 10.3390/jpm12101676Filev R, Rostaing L, Lyubomirova M et al. COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury. J Pers Med 2022;12(10):1676. doi: 10.3390/jpm12101676Ойноткинова ОШ, Мацкеплишвили СТ, Ларина ВН. и др. Влияние SARS-CoV-2 на мультиорганное поражение и реабилитационная тактика в постковидном периоде. Кардиология и сердечно-сосудистая хирургия 2022;15(2):202–214. doi: 10.17116/kardio202215021202Oynotkinova OSh, Matskeplishvili ST, Larina VN et al. The effect of SARS-CoV-2 on multi-organ damage and rehabilitation tactics in the post-COVID period. Kardiologiya i Serdechno-Sosudistaya Khirurgiya 2022;15(2):202–214. (In Russ.) doi: 10.17116/kardio202215021202Борисова ОВ, Маковецкая ГА, Мазур ЛИ и др. Пандемия COVID-19 и поражение почек у детей: обзор литературы и собственные региональные наблюдения. Медицинский Совет 2022;(1):134–141. doi: 10.21518/2079-701X-2022-16-1-134-141Borisova OV, Makovetskaya GA, Mazur LI et al. COVID-19 pandemic and kidney disease in children: literature review and own regional observations. Meditsinskiy sovet 2022;(1):134–141. (In Russ.) doi: 10.21518/2079-701X-2022-16-1-134-141Нуруллина ГИ, Халфина ТН, Исламова ГМ и др. Клинический случай острого повреждения почек у пациента с COVID-19. Практическая медицина 2022;20(1):129–132. doi: 10.32000/2072-1757-2022-1-129-132Nurullina GI, Khalfina TN, Islamova et al. Clinical case of acute kidney injury in a patient with COVID-19. Practical medicine 2022;20(1):129–132. (In Russ.) doi: 10.32000/2072-1757-2022-1-129-132Иванов ДД, Гоженко АИ, Иванова МД, Завальная ИН. Влияние COVID-19 на функцию почек у пациентов с артериальной гипертензией 1–2 степени и хронической болезнью почек. Нефрология 2022;26(1):34–43. doi: 10.36485/1561-6274-2022-26-1-34-43Ivanov DD, Gozhenko AI, Ivanova MD, Zavalnaya IN. Effect of COVID-19 on kidney function in patients with arterial hypertension grade 1-2 and CKD. Nephrology (Saint-Petersburg) 2022;26(1):34–43. (In Russ.) doi: 10.36485/1561-6274-2022-26-1-34-43

The authors declare that there are no conflicts of interest present.